Thus, the advantages of measuring urine cystatin B (and clusterin) are that concentrations can be monitored in the normal low range in kidneys lacking active inflammation and tissue damage, and then concentrations should be high with active renal inflammation and tissue damage, irrespective of presence or stage of CKD. This evidence concerns the gene CSTB and chronic kidney disease.